Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

Am J Health Syst Pharm. 2006;63(24):2466-2472. The rationale for the lack of clinically relevant weight gain with insulin detemir therapy has not yet been established. It may be attributed to ...